JP2013136631A5 - - Google Patents

Download PDF

Info

Publication number
JP2013136631A5
JP2013136631A5 JP2013055494A JP2013055494A JP2013136631A5 JP 2013136631 A5 JP2013136631 A5 JP 2013136631A5 JP 2013055494 A JP2013055494 A JP 2013055494A JP 2013055494 A JP2013055494 A JP 2013055494A JP 2013136631 A5 JP2013136631 A5 JP 2013136631A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
aryl
compound
deoxorapamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013055494A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013136631A (ja
Filing date
Publication date
Priority claimed from GBGB0601406.2A external-priority patent/GB0601406D0/en
Application filed filed Critical
Publication of JP2013136631A publication Critical patent/JP2013136631A/ja
Publication of JP2013136631A5 publication Critical patent/JP2013136631A5/ja
Pending legal-status Critical Current

Links

JP2013055494A 2006-01-24 2013-03-18 ラパマイシン誘導体の製造方法 Pending JP2013136631A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0601406.2 2006-01-24
GBGB0601406.2A GB0601406D0 (en) 2006-01-24 2006-01-24 Organic Compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008551707A Division JP5416412B2 (ja) 2006-01-24 2007-01-22 ラパマイシン誘導体の製造方法

Publications (2)

Publication Number Publication Date
JP2013136631A JP2013136631A (ja) 2013-07-11
JP2013136631A5 true JP2013136631A5 (https=) 2013-10-03

Family

ID=36060760

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008551707A Expired - Fee Related JP5416412B2 (ja) 2006-01-24 2007-01-22 ラパマイシン誘導体の製造方法
JP2013055494A Pending JP2013136631A (ja) 2006-01-24 2013-03-18 ラパマイシン誘導体の製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008551707A Expired - Fee Related JP5416412B2 (ja) 2006-01-24 2007-01-22 ラパマイシン誘導体の製造方法

Country Status (11)

Country Link
US (1) US8138344B2 (https=)
EP (1) EP1979359A1 (https=)
JP (2) JP5416412B2 (https=)
KR (1) KR101423343B1 (https=)
CN (2) CN104211716A (https=)
AU (1) AU2007209569B2 (https=)
BR (1) BRPI0707330A2 (https=)
CA (1) CA2637075A1 (https=)
GB (1) GB0601406D0 (https=)
RU (1) RU2448970C2 (https=)
WO (1) WO2007085400A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0601406D0 (en) * 2006-01-24 2006-03-08 Novartis Ag Organic Compounds
WO2014077577A1 (ko) * 2012-11-13 2014-05-22 엘지전자 주식회사 데이터 전송 방법 및 장치와, 데이터 전송 방법 및 장치
WO2014145780A1 (en) 2013-03-15 2014-09-18 Biosensors International Group, Ltd. Purification of rapamycin derivatives
EP3109250A1 (en) * 2015-06-23 2016-12-28 Synbias Pharma AG Method for the synthesis of rapamycin derivatives
AR112834A1 (es) 2017-09-26 2019-12-18 Novartis Ag Derivados de rapamicina
HRP20250197T1 (hr) 2018-12-18 2025-04-11 Novartis Ag Derivati rapamicina
IL285067B2 (en) 2019-01-22 2025-02-01 Aeovian Pharmaceuticals Inc MTORC Modulators and Their Uses
CN115776907B (zh) * 2020-03-27 2025-02-25 艾奥维安制药公司 Mtorc1调节剂及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256790A (en) * 1992-08-13 1993-10-26 American Home Products Corporation 27-hydroxyrapamycin and derivatives thereof
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
US5985890A (en) 1995-06-09 1999-11-16 Novartis Ag Rapamycin derivatives
EP1248869A2 (en) * 2000-01-07 2002-10-16 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
GB0601406D0 (en) * 2006-01-24 2006-03-08 Novartis Ag Organic Compounds

Similar Documents

Publication Publication Date Title
JP2013136631A5 (https=)
JP2019524861A5 (https=)
JP2010535722A5 (https=)
EP4458348A3 (en) Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof
MX2014015501A (es) Carboxamidas heterociclicas fungicidas.
SI2906563T1 (en) Derivatives of pyrrolo (3,2-d) pyrimidine for the treatment of viral infections and other diseases
MY192109A (en) Aminopyrimidinyl compounds as jak inhibitors
EP4424314A3 (en) Substituted polycyclic pyridone derivative and prodrug thereof
JP2017508789A5 (https=)
AR067413A1 (es) Compuestos heterociclicos que contienen ciclopenta[d]pirimidina inhibidores de proteinquinasas akt, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de las mismas para el tratamiento de enfermedades hiperproliferativas, tales como cancer
RU2017120970A (ru) Производные желчной кислоты в качестве агонистов fxr/tgr5 и способы их применения
PE20141205A1 (es) Spiro-[1,3]-oxacinas y spiro-[1,4]-oxacepinas como inhibidores de bace1 y/o bace2
JP2016515560A5 (https=)
JP2014506599A5 (https=)
NZ708801A (en) Aryl and heteroaryl fused lactams
NZ599040A (en) 2,4-disubstituted pyrido[4,3-d]pyrimidin-5(6h)-one compounds for selective inhibitors of lrrk2 and syk kinases
RU2013151803A (ru) Бициклические гетероциклические соединения и их применения в терапии
JP2015520140A5 (https=)
AR080596A1 (es) Compuestos alquilamido y composiciones farmaceuticas
RU2013126531A (ru) Селективные ингибиторы гликозидазы и их применение
PH12017501652A1 (en) Kv1.3 inhibitors and their medical application
RU2010125902A (ru) Способ получения замещенных гетероциклом производных пиридина
TR201902080T4 (tr) N-asil-(3-sübstitüe)-(8-sübstitüe)-5,6-dihidro-[1,2,4]triazolo[4,3-a]pirazinlerinin yeni kiral sentezleri.
RU2008134424A (ru) Способ получения производных рапамицина
PH12017501655B1 (en) Morphinan derivative